MOH expedites permanent roles for doctors to retain healthcare talent
He clarified that while international recruitment falls under regional labour agreements, the ministry is prioritising local retention. 'We cannot block cross-border recruitment, it's an individual right. This is also aligned with the Mutual Recognition Arrangement and the ASEAN Framework Agreement on Services,' he said during the ASEAN Dengue Day 2025 event.
The statement follows reports of Singaporean hospitals offering high salaries to attract Malaysian medical professionals. A recruitment drive targeting doctors is reportedly scheduled next month at a local hotel.
Dzulkefly assured that the ministry is fast-tracking permanent roles for contract doctors to address staffing shortages. 'We won't delay; we are expediting the process to absorb contract workers into permanent roles. As soon as there are vacancies, we will act,' he said.
The contract system was initially implemented to manage an influx of medical graduates, but with numbers now declining, Dzulkefly confirmed sufficient vacancies for permanent hires. - Bernama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
9 hours ago
- New Straits Times
Penang's medtech industry a 'hidden gem' with strong growth potential
GEORGE TOWN: Penang's medical technology (medtech) industry is rapidly emerging as one of the state's most promising sectors, driven by strong global demand, robust local capabilities, and a well-established ecosystem. InvestPenang chief executive officer Datuk Loo Lee Lian said the state's expertise in precision engineering and automation, developed through its thriving semiconductor industry, has been instrumental in the growth of the medtech sector in the state. "In the semiconductor industry, precision and automation are essential, and these competencies translate directly into the production of surgical instruments, implants, and high-accuracy medical devices. "In fact, medtech often requires even greater precision than the semiconductor industry," she told Bernama. The medtech sector also benefits from its synergies with the electrical and electronics manufacturing (ecosystem), as medical devices such as pacemakers, glucose monitoring systems, and diagnostic equipment rely on sophisticated electronic and mechanical components. Loo described the medtech sector as a "hidden gem" because unlike the cyclical semiconductor sector, it offers steady growth and higher profit margins, enabling companies to invest more in training talents. "This stability also attracts talent, as jobs in the sector are less vulnerable to sudden hiring freezes or retrenchments," she said. Globally, she noted, leading medtech clusters include the United States (US), Ireland, Puerto Rico, and Costa Rica, countries where government support has spurred industry growth over the past decade. In recent years, many companies have expanded into Asia due to rising cost pressures, shift in policies, and the region's growing, wealthier, and ageing population. She said companies find it attractive to set up operations in Penang when expanding into Asia, thanks to its mature industrial base, skilled workforce, and a well-developed supplier network. Moreover, local participation in the sector is also rising, with homegrown firms such as Straits Orthopaedics (Mfg) Sdn Bhd and UWC Healthcare, now serving the global market. Loo said InvestPenang has facilitated its growth by organising exhibitions and engagement sessions with the Health Ministry and industry partners to showcase products and encourage the companies' inclusion in government procurement. However, she noted that medtech companies in Penang face three key challenges: the US Trade Agreements Act which restricts the value of Malaysian-supplied products in US government contracts; geopolitical tensions and tariffs; and ongoing supply chain disruptions. Despite these hurdles, Loo is optimistic about prospects over the next five years and InvestPenang is constantly in talks with several medtech companies on potential investments. "With Asia's ageing and increasingly affluent population, demand for advanced medical devices is set to rise. We expect to see more global names here, particularly in higher-end products, and we aim to strengthen the role of local companies in this space," she added.
The Star
11 hours ago
- The Star
MCMC removed 2,033 unauthorised product ads since January, says Teo
JOHOR BAHRU: The Malaysian Communications and Multimedia Commission (MCMC) removed 2,033 advertisements related to products and services not authorised by the Health Ministry and other agencies from the start of this year until Aug 1, says Deputy Communications Minister Teo Nie Ching. She said the move followed 2,283 complaints received during the period, with the removal of such ads having been carried out since 2022. "In 2022, MCMC received eight complaints and removed all related ads. In 2023, 439 complaints were received and 390 ads were removed. Meanwhile, in 2024, MCMC received 3,312 complaints and took down 1,643 unauthorised online ads,' she said. She said this at a press conference after officiating the Johor-level MADANI MSME Digital Grant (GDPM) Festival 2025 in Permas Jaya here on Sunday (Aug 10). Teo said her ministry constantly works with the Health Ministry on false medicine or health service advertisements, as the Health Ministry has the expertise to identify such cases. "When we receive a complaint from the Health Ministry, MCMC will notify social media platform providers to take the advertisement down if it is unauthorised. "However, if a complaint is received from the public, for example involving fake medicines, we will refer it to the Health Ministry for verification before further action is taken,' she said.- Bernama
The Star
13 hours ago
- The Star
Malaysia can take the lead in managing the global obesity crisis
Obesity is a slow-moving emergency in Malaysia – creeping steadily through the population, raising healthcare costs, reducing productivity and contributing to rising levels of non-communicable diseases (NCDs). It is one of the defining public health challenges of the 21st century and Malaysia is on the front lines. We now have one of the highest adult obesity rates in South-East Asia, with over half of the adult population classified as overweight or obese, according to the 2023 National Health and Morbidity Survey (NHMS). The economic toll is no less alarming. Prevent the kilos, save the money According to the Health Ministry's Investment Case for the Prevention and Control of NCDs , obesity-related conditions cost our economy over RM5.2bil in 2017 alone. This was RM1.7bil in direct healthcare expenses and another RM3.5bil in productivity losses. The human and economic burden is substantial and growing. Yet, the same investment case provides a hopeful counterpoint: effective prevention could yield dramatic savings. The report shows that every ringgit invested in obesity prevention could return up to six ringgit in benefits through reduced health costs and productivity gains. Malaysia stands to save RM43bil over 15 years by implementing proven and cost-effective interventions, particularly through fiscal measures and nutrition strategies. These aren't theoretical solutions; they're policy tools with demonstrated success globally. For instance, expanding Malaysia's existing sugar-sweetened beverage (SSB) tax framework could yield measurable reductions in sugary drink consumption, while implementing school nutrition programmes would create vital structural protections for vulnerable youth populations. What makes these interventions particularly compelling is their dual benefit: they simultaneously save lives while generating significant economic returns. ALSO READ: Sugary drinks intake went up among kids, in tandem with obesity Addressing the problem Despite the facts, obesity remains under-addressed in Malaysia's health and development plans. While NCDs such as diabetes and cardiovascular (heart) disease often receive targeted action, obesity – their leading cause – is too often treated as a secondary concern, or worse, as a personal failing rather than what it is: a chronic disease driven by the interplay of genetic predisposition, food environment, exploitative marketing and socioeconomic factors. ALSO READ: Obesity is more complex than just overeating The global health community has increasingly recognised this complexity. Since 2018, obesity has been classified as a disease rather than simply a risk factor for other illnesses. This redefinition carries major implications, not only for treatment, but for policy, shifting the focus from individual willpower to systemic action. The case for action is not merely domestic. As Asean Chair and a participant in next month's (September 2025) fourth United Nations General Assembly High-Level Meeting (UN HLM) on NCDs, Malaysia has an historic opportunity to lead the global charge against obesity. Unfortunately, the current draft of the UN Political Declaration – scheduled for adoption at the meeting – fails to reflect the gravity of the obesity crisis. It stops short of naming obesity as a chronic disease, omits reference to several evidence- informed interventions recommendations of the World Health Organization (WHO) – including fiscal interventions such as taxes on SSBs of at least 20% – and uses weak language on addressing food systems in relation to prevention policy. This represents a missed opportunity and fails the one billion people living with obesity worldwide and future generations who are at increasing risk. Obesity accounts for around 43% of type 2 diabetes, up to 78% of hypertension (high blood pressure), and plays a role in at least 13 types of cancer. And yet, fewer than 20% of countries have meaningfully integrated obesity into their primary care systems, and effective policies, like SSB taxes, remain underutilised, despite a strong evidence base showing they reduce consumption and disease risk across income levels. Time for Malaysia to lead Malaysia's position on both the regional and global stage presents a unique opportunity. As Asean Chair, the country can lead a coordinated regional voice advocating for stronger commitments in the final UN declaration. That includes recognition of obesity as a disease, adoption of WHO-recommended policies to reshape food environments, and integration of obesity services into health systems. These elements are not just ethically and scientifically justified – they are economically rational. As Malaysia embarks on implementing its 13th development plan (i.e. 13th Malaysia Plan), it offers an excellent domestic vehicle to scale up obesity prevention in line with the Investment Case 's recommendations. The science is clear, the economic case is irrefutable, and the timing is politically opportune. Now is the moment for leaders to choose legacy over lethargy, and transform this slow-moving crisis into public health and public finance wins. Political and public health leaders have the chance to act on solid local evidence while championing global progress. It is no exaggeration to say that the cost of inaction will be counted in millions of lives lost and billions of ringgit drained from the economy. But the good news is that solutions exist. Malaysia, with its data in hand, its leadership role in Asean and its voice at the UN, is well placed to turn the tide – not only for its own population, but also as an advocate for equitable, systemic responses to obesity across the region and beyond. The challenge is not whether effective action is possible; it is whether the political will exists to deliver it before this slow- burning crisis becomes a full-blown catastrophe. History judges societies not by their crises, but by their responses. This is Malaysia's moment to lead, or be left behind. Dr Geeta Appannah is a professor of nutrition and dietetics at IMU University, president of the Malaysian Association for the Study of Obesity and member of the World Obesity Federation's Policy and Prevention Committee. Dr Kent Buse is a professor of health policy at Monash University Malaysia and chair of the World Obesity Federation's Policy and Prevention Committee. For more information, email starhealth@ The information provided is for educational and communication purposes only, and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this article. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
